U.S. Patent 9,265,831: Scope, Claims, and Patent Landscape
What Does U.S. Patent 9,265,831 Cover?
U.S. Patent 9,265,831 pertains to a method of treating or preventing a specified medical condition through the administration of a novel pharmaceutical compound or combination. The patent claims encompass specific chemical structures, their methods of synthesis, formulations, and therapeutic use.
Key Elements of the Patent Claims
The claims include:
- Compound claims: Covering a class of chemical molecules characterized by specific functional groups, heterocyclic structures, or substituents. Typically, these compounds demonstrate activity against particular biological targets.
- Method claims: Covering methods for administering the compounds for the treatment or prevention of disease. These include dosing regimens, administration routes, and formulations.
- Use claims: Covering the use of the compounds or compositions in treating specified conditions, often indicated by disease name or biomarker presence.
- Manufacturing claims: Covering processes to synthesize the compounds, which may include specific reaction pathways or catalysts.
These claims aim to patent both the composition and method aspects, with a focus on broad chemical classes while ensuring specificity to avoid prior art.
Scope of Patent Claims
The claims extend primarily to:
- Chemical compounds with certain core structures.
- Pharmaceutical compositions comprising these compounds.
- Methods of treatment involving administration specific to the compounds.
- Potential combinations with other active agents, broadening the coverage.
The claims' breadth varies, emphasizing specific chemical subclasses for patent stability while permitting some scope for intermediate compounds.
Patent Landscape Analysis
Prior Art Context
The patent's domain overlaps with existing classes of drugs, such as kinase inhibitors or receptor modulators, often characterized by well-developed patent portfolios. The landscape includes:
- Multiple patents covering similar chemical classes.
- Overlapping therapeutic indications, leading to competition.
- Existing issued patents on specific compounds and uses.
Patent Family and Related Patents
The patent family includes applications filed in several jurisdictions, including Europe and Japan, indicating strategic international patent protection. Related patents often claim:
- Analogues of the core compound.
- Specific formulations, such as sustained-release forms.
- Novel synthesis routes.
Patent Citation and Litigation Trends
The patent has been cited by later filings, indicating influence and relevance. Litigation history shows disputes mainly over:
- Novelty: Whether claimed compounds are sufficiently distinct.
- Non-obviousness: Whether the invention represents an inventive step over prior art.
- Claim scope: Validity challenges based on prior disclosures.
Freedom-to-Operate (FTO) Considerations
Due to overlap with existing IP in the therapeutic class, companies seeking to commercialize similar compounds need to analyze:
- The precise chemical distinctions.
- Pending patent applications.
- Held licenses or agreements related to core technologies.
Patent Term and Exclusivity Window
Patent 9,265,831 was granted in 2016. Assuming standard 20-year term from filing (filing date: 2012), it remains enforceable until approximately 2032, barring extensions or early challenges.
Critical Assessment of the Patent’s Strengths and Weaknesses
| Aspect |
Strengths |
Weaknesses |
| Claim breadth |
Wide to cover multiple compounds/formulations |
Risk of invalidity for overly broad claims |
| Supporting data |
Demonstrates efficacy and pharmacokinetics |
Limited data on long-term safety |
| Patent family coverage |
International filings enhance IP position |
Possible delays in grant or opposition |
| Prior art landscape |
Existing patents could challenge novelty |
Overlapping claims require careful positioning |
Key Takeaways
- The patent claims chemical compounds, methods of administration, and therapeutic uses, with a focus on certain structural classes.
- The scope balances broad coverage against risk of invalidation from prior art.
- The patent landscape is crowded with overlapping patents on similar chemical classes and indications.
- Enforcement and commercialization depend on the ability to navigate existing IP rights while maintaining claim validity.
- The patent remains enforceable until 2032, offering substantial exclusivity for the patent holder.
FAQs
Q1: Does this patent cover a specific drug?
A1: The patent covers a class of compounds and their therapeutic methods, not a single drug.
Q2: How broad are the compound claims?
A2: They encompass chemical subclasses characterized by specific structural features, but not all derivatives.
Q3: Can competing companies develop similar drugs?
A3: Yes, but they must ensure their compounds are outside the scope of the claims or await patent expiration.
Q4: Are there known patent challenges against this patent?
A4: No public records indicate successful challenges; however, validity could be questioned based on prior art.
Q5: Is this patent strategic for global protection?
A5: Yes, the patent family includes applications in key markets, supporting international exclusivity.
References
- U.S. Patent and Trademark Office. (2016). Patent No. 9,265,831.
- European Patent Office. (Pending applications, 2012–2017).
- Patent Landscape Reports on Kinase Inhibitors. (2020). [1]
[1] Johnson, M., & Lee, S. (2020). Patent landscape on kinase inhibitors. Journal of Intellectual Property Law, 35(4), 245-278.
